The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles
- PMID: 18443764
- DOI: 10.1007/s00210-008-0285-8
The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles
Abstract
Mammal heart tissue has long been assumed to be the exclusive domain of the M(2) subtype of muscarinic receptor, but data supporting the presence of other subtypes also exist. We have tested the hypothesis that muscarinic receptors other than the M(2) subtype are present in the heart as minor populations. We used several approaches: a set of competition binding experiments with pirenzepine, AFDX-116, 4-DAMP, PD 102807, p-F-HHSiD, AQ-RA 741, DAU 5884, methoctramine and tripinamide, blockage of M(1) muscarinic receptors using MT7 toxin, subtype-specific immunoprecipitation experiments and determination of phospholipase C activity. We also attempted to block M(1)-M(4) receptors using co-treatment with MT7 and AQ-RA 741. Our results show that only the M(2) subtype is present in the atria. In the ventricles, however, we were able to determine that 20% (on average) of the muscarinic receptors were subtypes other than M(2), with the majority of these belonging to the M(1) subtype. We were also able to detect a marginal fraction (6 +/- 2%) of receptors that, based on other findings, belong mainly to the M(5) muscarinic receptors. Co-treatment with MT7 and AQ-RA 741 was not a suitable tool for blocking of M(1)-M(4) receptors and can not therefore be used as a method for M(5) muscarinic receptor detection in substitution to crude venom. These results provide further evidence of the expression of the M(1) muscarinic receptor subtype in the rat heart and also show that the heart contains at least one other, albeit minor, muscarinic receptor population, which most likely belongs to the M(5) muscarinic receptors but not to that of the M(3) receptors.
Similar articles
-
Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves.Pharmacol Res. 2006 Nov;54(5):345-55. doi: 10.1016/j.phrs.2006.07.001. Epub 2006 Jul 8. Pharmacol Res. 2006. PMID: 16965921
-
Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors.Eur J Pharmacol. 2008 Dec 3;599(1-3):146-51. doi: 10.1016/j.ejphar.2008.10.008. Epub 2008 Oct 10. Eur J Pharmacol. 2008. PMID: 18938154
-
Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex.Mol Pharmacol. 2002 Jun;61(6):1267-72. doi: 10.1124/mol.61.6.1267. Mol Pharmacol. 2002. PMID: 12021386
-
Muscarinic M3 receptor subtype gene expression in the human heart.Cell Mol Life Sci. 2000 Jan 20;57(1):175-80. doi: 10.1007/s000180050507. Cell Mol Life Sci. 2000. PMID: 10949589 Free PMC article.
-
Characterization of muscarinic cholinergic receptor subtypes in rat prostate.J Recept Signal Transduct Res. 1998 Mar-May;18(2-3):151-66. doi: 10.3109/10799899809047742. J Recept Signal Transduct Res. 1998. PMID: 9651883 Free PMC article.
Cited by
-
Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb;385(2):125-35. doi: 10.1007/s00210-011-0700-4. Epub 2011 Nov 10. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22071576
-
Initial characterization of M2-muscarinic receptor overexpressing mouse heart.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 13. doi: 10.1007/s00210-025-04502-3. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40802009
-
M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice.J Pharmacol Exp Ther. 2009 Aug;330(2):487-93. doi: 10.1124/jpet.109.153304. Epub 2009 May 8. J Pharmacol Exp Ther. 2009. PMID: 19429792 Free PMC article.
-
How reliable are G-protein-coupled receptor antibodies?Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):385-8. doi: 10.1007/s00210-009-0395-y. Epub 2009 Jan 27. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 19172248
-
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4.Sci Rep. 2017 Nov 9;7(1):15222. doi: 10.1038/s41598-017-15632-x. Sci Rep. 2017. PMID: 29123207 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources